Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5


The 5′ cap structures of higher eukaryote mRNAs have ribose 2′-O-methylation. Likewise, many viruses that replicate in the cytoplasm of eukaryotes have evolved 2′-O-methyltransferases to autonomously modify their mRNAs. However, a defined biological role for 2′-O-methylation of mRNA remains elusive. Here we show that 2′-O-methylation of viral mRNA was critically involved in subverting the induction of type I interferon. We demonstrate that human and mouse coronavirus mutants lacking 2′-O-methyltransferase activity induced higher expression of type I interferon and were highly sensitive to type I interferon. Notably, the induction of type I interferon by viruses deficient in 2′-O-methyltransferase was dependent on the cytoplasmic RNA sensor Mda5. This link between Mda5-mediated sensing of viral RNA and 2′-O-methylation of mRNA suggests that RNA modifications such as 2′-O-methylation provide a molecular signature for the discrimination of self and non-self mRNA.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Conservation of viral 2′-O-methyltransferases.
Figure 2: The HCoV 2′-O-methyltransferase mutant has altered replication kinetics and induction of and sensitivity to type I interferon.
Figure 3: MHV 2′-O-methyltransferase mutants induce IFN-β in an Mda5-dependent manner.
Figure 4: MHV 2′-O-methyltransferase mutants induce the nuclear localization of IRF3 in an Mda5-dependent manner.
Figure 5: Differences in the effect of type I interferon on the replication of MHV 2′-O-methyltransferase mutants.
Figure 6: Restoration of MHV-D130A replication in IFIT1-deficient macrophages.
Figure 7: Deficiency in 2′-O-methyltransferase affects the recognition of virus by the innate immune system in vivo.

Accession codes




  1. 1

    Janeway, C.A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).

  2. 2

    Takeuchi, O. & Akira, S. Innate immunity to virus infection. Immunol. Rev. 227, 75–86 (2009).

  3. 3

    Loo, Y.M. & Gale, M. Jr. Viral regulation and evasion of the host response. Curr. Top. Microbiol. Immunol. 316, 295–313 (2007).

  4. 4

    Haller, O. & Weber, F. Pathogenic viruses: smart manipulators of the interferon system. Curr. Top. Microbiol. Immunol. 316, 315–334 (2007).

  5. 5

    Hui, D.J., Terenzi, F., Merrick, W.C. & Sen, G.C. Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. J. Biol. Chem. 280, 3433–3440 (2005).

  6. 6

    Terenzi, F., Hui, D.J., Merrick, W.C. & Sen, G.C. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J. Biol. Chem. 281, 34064–34071 (2006).

  7. 7

    Fensterl, V. & Sen, G.C. The ISG56/IFIT1 gene family. J. Interferon Cytokine Res. published online, doi:10.1089/jir.2010.0101 (25 October 2010).

  8. 8

    Kato, H. et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205, 1601–1610 (2008).

  9. 9

    Hornung, V. et al. 5′-triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006).

  10. 10

    Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997–1001 (2006).

  11. 11

    Schlee, M. et al. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31, 25–34 (2009).

  12. 12

    Ghosh, A. & Lima, C.D. Enzymology of RNA cap synthesis. WIREs RNA 1, 152–172 (2010).

  13. 13

    Shuman, S. What messenger RNA capping tells us about eukaryotic evolution. Nat. Rev. Mol. Cell Biol. 3, 619–625 (2002).

  14. 14

    Nomoto, A., Detjen, B., Pozzatti, R. & Wimmer, E. The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature 268, 208–213 (1977).

  15. 15

    Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).

  16. 16

    Bouvet, M. et al. In vitro reconstitution of SARS-coronavirus mRNA cap methylation. PLoS Pathog. 6, e1000863 (2010).

  17. 17

    Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl. Acad. Sci. USA 106, 3484–3489 (2009).

  18. 18

    Decroly, E. et al. Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2′-O)-methyltransferase activity. J. Virol. 82, 8071–8084 (2008).

  19. 19

    Snijder, E.J. et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331, 991–1004 (2003).

  20. 20

    Feder, M., Pas, J., Wyrwicz, L.S. & Bujnicki, J.M. Molecular phylogenetics of the RrmJ/fibrillarin superfamily of ribose 2′-O-methyltransferases. Gene 302, 129–138 (2003).

  21. 21

    Schnierle, B.S., Gershon, P.D. & Moss, B. Cap-specific mRNA (nucleoside-O2′-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein. Proc. Natl. Acad. Sci. USA 89, 2897–2901 (1992).

  22. 22

    Cervantes-Barragán, L. et al. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 182, 1099–1106 (2009).

  23. 23

    Cervantes-Barragan, L. et al. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109, 1131–1137 (2007).

  24. 24

    Rose, K.M., Elliott, R., Martinez-Sobrido, L., Garcia-Sastre, A. & Weiss, S.R. Murine coronavirus delays expression of a subset of interferon-stimulated genes. J. Virol. 84, 5656–5669 (2010).

  25. 25

    Roth-Cross, J.K., Bender, S.J. & Weiss, S.R. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82, 9829–9838 (2008).

  26. 26

    Zhou, H., Zhao, J. & Perlman, S. Autocrine interferon priming in macrophages but not dendritic cells results in enhanced cytokine and chemokine production after coronavirus infection. MBio 1, e00219–10 (2010).

  27. 27

    Bocharov, G. et al. A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections. PLoS Pathog. 6, e1001017 (2010).

  28. 28

    Daffis, S. et al. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468, 452–456 (2010).

  29. 29

    Thiel, V. & Weber, F. Interferon and cytokine responses to SARS-coronavirus infection. Cytokine Growth Factor Rev. 19, 121–132 (2008).

  30. 30

    Loo, Y.M. et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82, 335–345 (2008).

  31. 31

    Morin, B. et al. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog. 6, e1001038 (2010).

  32. 32

    Reguera, J., Weber, F. & Cusack, S. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog. 6, e1001101 (2010).

  33. 33

    Qi, X. et al. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature advance online publication, doi:10.1038/nature09605 (17 November 2010).

  34. 34

    Le Gall, O. et al. Picornavirales, a proposed order of positive-sense single-stranded RNA viruses with a pseudo-T = 3 virion architecture. Arch. Virol. 153, 715–727 (2008).

  35. 35

    Gitlin, L. et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103, 8459–8464 (2006).

  36. 36

    Nallagatla, S.R. & Bevilacqua, P.C. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner. RNA 14, 1201–1213 (2008).

  37. 37

    Karikó, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).

  38. 38

    Nallagatla, S.R., Toroney, R. & Bevilacqua, P.C. A brilliant disguise for self RNA: 5′-end and internal modifications of primary transcripts suppress elements of innate immunity. RNA Biol. 5, 140–144 (2008).

  39. 39

    Eriksson, K.K., Makia, D. & Thiel, V. Generation of recombinant coronaviruses using vaccinia virus as the cloning vector and stable cell lines containing coronaviral replicon RNAs. Methods Mol. Biol. 454, 237–254 (2008).

  40. 40

    Züst, R. et al. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog. 3, e109 (2007).

  41. 41

    Wünschmann, S., Becker, B. & Vallbracht, A. Hepatitis A virus suppresses monocyte-to-macrophage maturation in vitro. J. Virol. 76, 4350–4356 (2002).

  42. 42

    Uzé, G. et al. Domains of interaction between α interferon and its receptor components. J. Mol. Biol. 243, 245–257 (1994).

  43. 43

    Bryson, K. et al. Protein structure prediction servers at University College London. Nucleic Acids Res. 33, W36–W38 (2005).

  44. 44

    Fauman, E.B., Blumenthal, R.M. & Cheng, X. Structure and Evolution of AdoMet-Dependent Methyltransferases. in S-Adenosylmethionine-Dependent Methyltransferases: Structures and Functions (eds. Cheng, X. & Blumenthal, R.M.) 1–38 (World Scientific, Singapore, 1999).

  45. 45

    Waterhouse, A.M., Procter, J.B., Martin, D.M., Clamp, M. & Barton, G.J. Jalview Version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189–1191 (2009).

  46. 46

    Gosert, R., Kanjanahaluethai, A., Egger, D., Bienz, K. & Baker, S.C. RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J. Virol. 76, 3697–3708 (2002).

Download references


We thank V. Lohmann (University of Heidelberg) for Huh-7 cells; G.L. Smith (Imperial College, London) for D980R cells; S.G. Sawicki (Medical University of Ohio) for 17Cl1 cells; M. Pelegrin (Institut de Génétique Moléculaire de Montpellier) for LL171 cells; L. Onder for assistance with fluorescence microscopy; and R. de Giuli, B. Schelle and N. Karl for technical assistance. This study was supported by the Swiss National Science Foundation, the European Commission (TOLERAGE), the Novartis Foundation for Biomedical Research, Switzerland, the German Ministry of Education and Research (V.T.), the Austrian Science Fund (FWF J3044 to M.H.), Deutsche Forschungsgemeinschaft (J.Z.), the National Institutes of Health (AI060915 and AI085089 to S.C.B.; U54 AI081680 (Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research to M.S.D), the Medical Research Council (B.W.N.) and the Wellcome Trust (S.G.S.).

Author information

R.Z., L.C.-B., M.H., R.M. and K.J.S. did most of the experiments; B.W.N. did phylogenetic analyses; B.W.N. and S.C.B. did electron microscopy; J.Z., S.C.B., W.B., M.S.D., S.G.S. and B.L. contributed reagents and expertise; and S.G.S., B.W.N., B.L. and V.T. conceived of and designed the project and wrote and edited the manuscript.

Correspondence to Volker Thiel.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–2 and Supplementary Table 1 (PDF 394 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Züst, R., Cervantes-Barragan, L., Habjan, M. et al. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 12, 137–143 (2011) doi:10.1038/ni.1979

Download citation

Further reading